MRK Stock Recent News
MRK LATEST HEADLINES
Merck (MRK) reachead $123.99 at the closing of the latest trading day, reflecting a +0.19% change compared to its last close.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Participate in the Barclays 26th Annual Global Healthcare Conference.
In the most recent trading session, Merck (MRK) closed at $126.96, indicating a -0.15% shift from the previous trading day.
Merck: A Great Dividend Growth Stock, But Not At This Price
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Despite markets continuing at record highs, Charles Schwab (NYSE: SCHW ) Investment Management still identifies investment opportunities within long-term stocks. According to its recent filings, the respected investment house perceives potential upside in interesting companies, increasing holdings.
Merck has received a letter that Hikma Pharmaceuticals US unit has sought a pre-patent expiry approval from the US FDA to sell a generic version of its Bridion injection, the drugmaker said in filing on Monday.
Amid a frenzy for AI-related stocks, shares of a little-known biotech company in South Korea got an Nvidia-esque boost. Alteogen, a pharmaceutical company with nothing to do with AI, saw its share price jump about 25% Friday to an all-time high after it announced a licensing deal with drug giant Merck.
2 Dow Stocks That Have Been Most Overbought Since The 1970s
Merck's (MRK) Animal Health unit is set to strengthen its position with the acquisition of Elanco Animal Health's aqua business for $1.3 billion. The transaction is expected to close by mid-2024.